CompletedPhase 4NCT00176943

Characteristics of T Cells From Alopecia Areata Scalp Skin Before and After Treatment With Aldara 5%

Studying Alopecia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hordinsky, Maria K., MD
Principal Investigator
Maria Hordinsky, MD
University of Minnesota
Intervention
Aldara Cream 5%(drug)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20002002

Study locations (1)

Collaborators

National Alopecia Areata Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00176943 on ClinicalTrials.gov

Other trials for Alopecia

Additional recruiting or active studies for the same condition.

See all trials for Alopecia

← Back to all trials